Skip to main content

and
  1. No Access

    Article

    Allocating healthcare resources to genomic testing in Canada: latest evidence and current challenges

    Precision medicine (PM) informed by next-generation sequencing (NGS) poses challenges for health technology assessment (HTA). To date, there has been limited reimbursement of genomic testing with NGS in Canada...

    Deirdre Weymann, Nick Dragojlovic, Samantha Pollard in Journal of Community Genetics (2022)

  2. No Access

    Article

    Balancing uncertainty with patient autonomy in precision medicine

    By the nature of their unknown pathogenicity, variants of unknown significance (VUS) should not inform clinical decisions for genetic carrier testing; nevertheless, VUS are increasingly returned to patients. W...

    Samantha Pollard, Sophie Sun, Dean A. Regier in Nature Reviews Genetics (2019)